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Abstract  
OBJECTIVE: To evaluate the levels of serum vitamin D (25-hydroxyvitamin D) among obese 
Egyptian females and search possible association with cognitive functions and insulin resistance. 
SUBJECTS AND METHODS: This study included 2 groups, Group-1(cases) consists of 120 obese 
females and Group-2 (controls) consists of 30 non-obese females. The included females were 
subjected to full clinical examination, anthropometric measurements and Kendrick Battery for 
evaluation of cognitive functions (short term memory and attention). Evaluation of serum Vitamin D, 
Parathyroid hormone, C-peptide and fasting blood glucose were done. The obese group was put on 
a balanced low caloric diet (900-1000 K Calories/day) for 2 months, where reevaluation was 
performed. 
RESULTS: Comparing obese group with non-obese control group revealed significant lower mean 
level of serum vitamin D associated with significant lower cognitive functions test and higher fasting 
blood glucose. After 2 months of low caloric diet, a significant increase in the serum level of vitamin 
D, accompanied with improvement in cognitive functions and decrease in fasting blood glucose and 
improved insulin resistance was seen. A correlation is found between vitamin D serum level and 
cognitive functions. 
CONCLUSION: A lower vitamin D serum level could be a modifiable risk factor for obesity, insulin 
resistance and cognitive impairment in middle age females. 
  
 
Introduction 
Several studies suggested that lower vitamin 
D (25-hydroxyvitamin D) concentrations are 
associated with poorer cognitive function and a higher 
risk of Alzheimer’s disease (AD) [1, 2]. Low vitamin D 
(VD) concentrations are prevalent worldwide for all 
age groups [3, 4]. The VD insufficiency may be a 
modifiable risk factor for dementia as the role of VD in 
brain function is becoming clearer. Vitamin D 
receptors are located in the human cortex and 
hippocampus, which are key areas for cognition. At 
the molecular level, the brain has the ability to 
synthesize the active form of VD (1, 25-
dihydroxyvitamin D) within many cell types and 
regions with predominance in the hypothalamus and 
the large neurons within the substantia nigra. 
Functionally, VD contributes to neuroprotection by 
modulating the production of nerve growth factor [5]. 
A systematic review summarized studies that 
contained measurements of VD and related these to 
measures of cognition or dementia [6]. The meta-
analyses showed Mini Mental State Examination 
(MMSE) scores were lower in individuals with lower 
VD concentrations, and that individuals with AD had 
lower VD concentrations compared to those without 
AD. The studies included various populations, study 
numbers, study designs, cognitive tests, confounders, 
statistical tests, VD methods, and groupings [7, 8]. 
As with obesity, VD deficiency is reaching 
epidemic proportions worldwide, in both pediatric as 
well as adult populations [9]. Evidence is 
accumulating to suggest that there is a potential link 
between obesity and VD deficiency among global 
populations [10].  Several studies reported low serum 
level of VD in obese individuals [11]. Beyond VD's 
historic role in bone mineralization to its more recent 
association with allergy development reports to date 
have linked VD deficiency to hypertension, diabetes 
mellitus and insulin resistance (IR), non-alcoholic fatty 
liver disease (NAFLD) and cognitive impairment [12]. 
Several studies suggested that glucose 
metabolism and body fat content depend on serum 
VD levels. Consequently, VD deficiency may no 
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longer be a condition, but rather a mediator of 
metabolic diseases responsible for the long-term 
health outcomes of obese population [13]. A study 
showed that low VD levels are associated with 
increased plasma glucose levels and decreased 
insulin sensitivity index [14]. A lower VD level could be 
a risk factor for developing insulin resistance and type 
2 diabetes in obese population [15]. Excess body fat 
is associated with an increased risk of suboptimal VD 
status, it is unclear as to whether poor VD status is a 
consequence of obesity or is actively involved in its 
development. Until now, data regarding the role of VD 
are inconclusive [16]. The link between cognitive 
impairment and obesity has been reported in previous 
studies mediated through insulin resistance [17, 18]. 
The VD deficiency may be an additional mode of 
action that contributes to the cognitive impairment 
reported in the obese individuals.  
The primary objective of this study is to 
evaluate levels of serum VD [25(OH) D] among obese 
Egyptian females and search for possible association 
with cognitive functions, serum blood glucose and 
insulin resistance. 
 
Subjects and Methods 
Subjects 
This study included 2 groups; Group 1 (cases) 
consists of 120 obese female, mean BMI (38.4 ± 6.9), 
and Group 2 (controls) consists of 30 non-obese 
females, mean BMI (24.1 ± 1.2), mean age for both 
groups (47.8 ± 6.4 years). Both groups were of 
matching social, educational, medical and 
environmental background. They were all working 
females and belonged to middle social class. All 
cases were enrolled in a program for losing weight at 
the Nutrition Department at the National research 
center. The protocol of the study was approved by the 
National Research Center Ethics Committee. In 
addition an informed consent was obtained from each 
participant to be included in the study. 
Inclusion criteria were that: they were not 
suffering from any mental, neurological or critical 
health problems, and not receiving drugs or nutritional 
supplements that affect cognitive functions or 
evaluated biochemical variables 
 
Methods 
All included cases were subjected to:  
1 - Full clinical examination and assessment 
of blood pressure.  
2 - Evaluation of cognitive functions and 
detection of dementia. Kendrick Battery for the 
Detection of Dementia was used for assessing 
memory status and attention [19]. The battery consists 
of two tests: a - The Object Learning Test (OLT): a 
test of recall of everyday objects after viewing for a 
brief period (assessment of memory and recalling). 
The OLT consists of four cards and has two forms, A 
and B for test-retest. It has a possible maximum score 
of 70. Dementia is diagnosed if the individual got a 
score less than 26 points, and in this case she is 
excluded from the study. A higher OLT score indicates 
better memory status. b - The Digit Copying Test 
(DCT): a simple test of speed- performance (to assess 
attention and focus). It consists of a 10 by 10 matrix of 
the digits 0-9 each occurring randomly ten times 
within the matrix, the upper limit of the DCT is not 
defined. Dementia is detected if the volunteer needed 
2 minutes or more to finish copying the digits. The 
given scores are the number of seconds needed to 
finish copying the matrix. The less time taken the 
better is the level of attention and vice-versa, the 
score is inversely related to the attention status. Both 
tests are timed. 
3 - The anthropometric examination: Measu-
rements of height and body weight were taken 
according to standard method. Body mass index 
(BMI) = weight in kg/square height in meters was 
calculated. 
4 - Blood sampling and Biochemical analysis: 
Blood samples were drawn in the morning from all 
subjects after twelve hours fasting. The blood samples 
were allowed to clot, centrifuged and sera separated. -
Fasting blood glucose (FBG) was determined in fresh 
sera using the oxide peroxidase method [20]. The 
remaining sera were divided into aliquots and stored 
in eppindorf tubes at –70 
o
C until used for further 
analysis. - Serum C-peptide was determined by 
Immunospec Corporation ELISA Kit 9428 Eton 
Ave,Unit 0 chats worth CA 91311 catalog No E1- 071 
[21]. - According to Li et al. (2004) [22], insulin 
resistance was expressed by modified homeostasis 
model assessment-insulin resistance (M.HOMA-IR) 
=1.5+ FBG (mg/dl) ×fasting C-peptide (ng/ ml) / 2800, 
in which insulin was replaced by C-peptide so as to be 
applied on diabetic patients using exogenous insulin. -
Serum 25 hydroxy vitamin D (25 (OH) D) was 
assessed by Vitamin D direct ELISA kit (EIA-4696) 
DRG ® International, Inc. USA [23]. - Serum 
parathyroid hormone (PTH) was measured by human 
PTH ELISA kit (hPTH-EASIA)  KAP1481 DIAsource 
ImmunoAssays S.A. - Rue de l'Industrie, 8 - B-1400 
Nivelle – Belgium [24]. The obese group was put on a 
balanced low caloric (900-1000 K calories/ day) diet 
for 2 months, A clear detailed sheet for the diet 
regimen was given at the first visit to each patient, 
weekly follow up was performed to assure exact and 
correct adherence to the diet, no VD supplementation 
was given. 
 
Study design and Statistics 
This is a comparative case-control study 
between obese cases and normal BMI control. Also to 
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compare data before and after 2 month of balanced 
low caloric diet among the obese group t-student tests 
were used. Correlations of data at the base line were 
also performed. Statistical analysis was performed 
using SPSS (10) software. Data is expressed as 
means ± SD. Pearson’s correlation coefficient (r) was 
calculated to find correlations between different 
variables. P value considered significant at< 0.05. 
 
Results 
Table 1 shows a significant (P = 0.000) lower 
vitamin D serum levels among the obese group (47.6 
± 7.7 nmol/L) compared to the normal non obese 
group (68.3 ± 9.3 nmol/L) which is still below the 
adequate level (≥ 75 nmol/L). Also a significant 
difference is seen in cognitive functions test results; 
both the short memory and attention, where the 
control non obese group showed statistically 
significant better results (P = 0.000). In addition, the 
mean fasting blood glucose (FBG) (119.5 ± 40 mg/dl) 
is significantly higher than the control group (82.1 ± 
6.7mg/dl) (P = 0.000). 
Table 1:  T –test to compare means between Group (1) obese 
cases and Group (2) normal controls at base line.  
 
Variables Mean ± SD P-value 
BMI (kg/m
2
) cases (no.=120) 38.4 ± 6.9 .000 
BMI(kg/m
2
) control (no.=30) 24.1 ± 1.2  
Vitamin D cases (nmol/L) 47.6 ± 7.7 .000 
Vitamin D control (nmol/L) 68.3 ± 9.3  
Memory(OLT) cases 41.5 ± 4.1 .000 
Memory(OLT) control 44.0 ± 2.7  
Attention(DCT) cases 82.8 ± 12 .000 
Attention(DCT) control 72.3 ± 7  
FBG (mg/dl) cases 119.5 ± 40 .000 
FBG (mg/dl) control 82.1 ± 6.7  
 P-value is significant at 0.000. 
 
Table 2 shows the changes occurred on the 
obese group after the 2 months on balanced low 
caloric diet comparing data before versus after the 
diet; significant decrease in the BMI and increase in 
mean VD level from (47.6 ± 7.7 nmol/L) to (53.5 ± 8.4 
nmol/L) (P = 0.000) accompanied by significant 
improvement in memory and attention scores (P = 
0.000) and decrease in FBG (P = 0.003) and 
improved insulin resistance (P = 0.029). Insignificant 
decrease in serum parathyroid hormone levels is 
seen. 
 
Table 2: Paired t –test to compare means of Group (1) obese 
group before (B) and after (A) two months of low caloric diet. 
Variables Mean ± SD P-value 
BMI  (kg/m
2
) (B) 38.4 ± 6.9 .000 
BMI (kg/m
2
) (A)   36.5 ± 6.7 
 
Vitamin D (nmol/L) (B) 47.6 ± 7.7 .000 
Vitamin D (nmol/L) (A)   53.5 ± 8.4 
 
OLT (B) 41.5 ± 4.1 .000 
OLT(A)   43.0 ± 3.9 
 
DCT(B) 82.8 ± 12 .000 
DCT(A)   78.9 ± 11 
 
F BG (mg/dl) (B) 119.5 ± 40 .003 
FBG (mg/dl) (A)   104 ± 28.4 
 
M.HOMA-IR  (B) 1.62 ± 9.3E-02 .029 
M.HOMA-IR (A)   1.58 ± 4.9E-02 
 
C-Peptide (ng/ml) (B) 2.6 ± 1.1 .016 
C-Peptide (ng/ml) (A) 2.2 ± 1.0 
 
PTH  (pg/ml) (B) 82.9 ± 16.2 NS 
PTH (pg/ml) (A)   80.1 ± 13 
 
P-value is significant at <0.05. 
Table 3 shows a significant positive 
correlation between VD serum level and cognitive 
functions [short-term memory (P = 0.039), and 
attention scores (P = 0.014)], while VD correlates 
negatively with PTH levels (P = 0.004). 
Table 3: Correlation between different variables at the base line 
for Group (1) obese patients. 
 
Variables Vitamin D DCT C-peptide  FBG 
BMI (Kg/m
2
)   r=0.487** 
P= .009 
r=0.414* 
P=.026 
M.HOMA-IR  r=0.382* 
P=.041 
r=0.863** 
p=.000 
r=.864** 
P=.000 
(Memory) OLT . r=385* 
P=.0.039 
  r=0.374* 
P=.046 
(Attention)  DCT r=-0.450* 
P=.014 
  r=-0.446* 
P=.015 
PTH (pg/ml) r=-0.513** 
P=.004 
r=0.377* 
P=.044 
  
Numbers presented in this table are the value of r =correlation coefficient. Correlation is 
significant at the 0.05 level; Correlation is significant at the 0.01 level. 
 
 
Discussion 
In our study the obese group showed vitamin 
D (VD) deficiency (47.6 ± 7.7 nmol/L). Most studies 
define deficiency as less than 50 nmol/L, the non-
obese controls show a significantly higher VD (68.3 ± 
9.3) levels but is still considered below the adequate 
level (≥ 75 nmol/L). It is important to mention this 
classification for VD Information from American 
Society of Bone and Mineral Research (ASBMR), 
2006: Deficiency (seriously deficient) < 12 ng/ml 
resp. < 30 nmol/l, Insufficiency (deficient) 12 - 30 
ng/ml resp. 30 - 75 nmol/l, Sufficiency (adequately 
supplied) > 30 ng/ml resp. > 75 nmol/l (Society of 
Osteology SACHSEN E. V. 
Several studies reported that low VD status is 
highly prevalent worldwide, and the major 
determinants are sun exposure and vitamin D intake 
[25, 26]. Another study reported that VD deficiency 
was highly prevalent among studied Saudi women 
who suffer from obesity, poor sunlight exposure and 
poor dietary VD supplementation [27]. In our study, 
the significant low level of VD compared to normal 
BMI controls can be explained by several 
mechanisms. A study suggested that VD deficiency 
increases appetite and decreases energy 
consumption leading to obesity. Another recent study 
suggested that the subcutaneous fat, which is known 
to store vitamin D, sequestered more of the cutaneous 
synthesized vitamin D3 in the obese than in the non-
obese subjects because there was more fat available 
for this process. Because obese people have a larger 
body surface area, they present with a decreased 
release of endogenously produced VD in the 
circulation because of the vitamin's increased storage 
in subcutaneous fat. It is, however, unclear as to 
whether poor VD status is a consequence of obesity 
or is actively involved in its development [28-30]. 
Important study on VD deficiency and 
insufficiency on population in Eastern Africa, females 
reported lower serum concentration, with the younger 
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population having lower serum concentrations than 
the elderly. Similarly central obesity was also highly 
prevalent in this population. The odds of being VD 
deficient were 3.3 times higher among individuals with 
elevated waist circumference than those with normal 
waist circumferences. Among the males, the odds of 
being Vitamin D deficient and having an elevated 
waist circumference was 6.8 times higher than for 
males with normal waist circumferences. Their 
conclusion was living on or close to the equator and 
having overhead or near overhead sunshine 
throughout the year in and of itself is not a guarantee 
of adequate serum VD concentrations [11]. 
Another important finding in our study is that 
lower VD level is accompanied by lower cognitive 
functions scores. This finding has been mentioned in 
several recent studies relating cognitive impairment to 
low VD levels. A meta-analysis study compared mean 
cognitive functions scores between individuals with 
vitamin D <50 and ≥50 nmol/L. The vitamin D cut point 
of 50 nmol/L was selected, as it was the most 
common cut point reported in these studies, and is 
commonly used to define vitamin D deficiency. Eight 
cross-sectional and case-control studies, which 
included data from 2749 participants, contributed to 
this analysis. Taken together, these studies showed a 
higher average MMSE score in participants with 
higher VD concentrations [7, 31, 32]. The role of VD in 
skeletal health is well established, but more recent 
findings have also linked VD deficiency to a range of 
non-skeletal conditions such as cardiovascular 
disease, cancer, stroke and metabolic disorders 
including diabetes. Cognitive impairment and 
dementia must now be added to this list [28, 31]. VD 
receptors are widespread in brain tissue, and VD's 
biologically active form [1, 25 (OH) 2D3] has shown 
neuroprotective effects including the clearance of 
amyloid plaques, a hallmark of Alzheimer's disease. 
Associations have been noted between low VD and 
Alzheimer's disease and dementia in both Europe and 
the US. Similarly, the risk of cognitive impairment was 
up to four times greater in the severely deficient elders 
(VD< 25 nmol/L) in comparison with individuals with 
adequate levels (≥ 75 nmol/L), two large prospective 
studies recently indicated that low VD concentrations 
may increase the risk of cognitive decline. A study 
reported that hypovitaminosis D is associated with 
global cognitive impairment in adults [1-4, 33]. 
Another 25 cross-sectional studies showed, a 
statistically significant worse outcome on one or more 
cognitive function tests or a higher frequency of 
dementia with lower VD levels or intake in 18 out of 25 
(72%) studies, whereas 7 (28%) studies failed to show 
an association. Four out of 6 (66.7%) prospective 
studies showed a higher risk of cognitive decline after 
a follow-up period of 4-7 years in participants with 
lower VD levels at baseline.  
In conclusion, these results suggest that lower 
VD concentrations are associated with poorer 
cognitive function and a higher risk of AD [1-3, 6-8]. 
Another important finding in our study that 
fasting blood glucose is significantly higher in the 
obese group with lower vitamin D level. After 2 
months of balanced low caloric diet a significant 
increase in mean VD is seen, accompanied by 
significant decrease in fasting blood sugar, improved 
insulin resistance and improved cognitive functions 
scores. So a link between VD levels and insulin 
resistance and serum blood glucose is seen adjoining 
the cognitive functions. We think that since 
subcutaneous fat, which is known to store VD, 
sequestered more of the cutaneous synthesized VD3 
in the obese than in the non-obese subjects because 
there was more fat available for this process, then by 
losing fat and reduced BMI after the diet, VD is freed 
from the fat cells and escape to the blood. This in 
return improve the cognitive functions either directly 
through the neuroprotective action of VD previously 
mentioned or through the improved insulin resistance 
seen. Our results are supported by other studies that 
reported low VD levels were associated with 
increased insulin resistance and higher blood glucose 
in middle-aged and elderly Korean adults, especially 
among those who were overweight or obese. Korean 
girls with low VD levels could be at increased risk for 
metabolic disorders. The study supports the favorable 
effects of vitamin D supplementation on reducing 
insulin resistance [34-36]. A lower VD level could be a 
risk factor for developing insulin resistance and type 2 
diabetes in the obese population. A study suggested 
that glucose metabolism and body fat content depend 
on serum levels of VD .The study showed that low VD 
levels were associated with obesity, increased plasma 
glucose levels and decreased insulin sensitivity index 
[36, 37]. 
On the other hand a study reported that 
correcting low VD levels in obese adolescents 
improves insulin sensitivity. Adolescents who took 
4000 IU of vitamin D3 daily had lower fasting insulin 
levels and insulin resistance than controls. Serum 
25(OH) D had a negative relationship with fasting 
glucose and insulin resistance index [homeostasis 
model assessment-insulin resistance (HOMA-IR)] 
[38]. A previous study showed that intramuscular 
vitamin D decreases insulin sensitivity in pre-diabetic 
patients. Serum 25(OH) vitamin D [25 (OH) D] was 
found to be statistically associated with fasting insulin 
and HOMA-IR [39, 40] in all participants except for the 
fasting insulin in participants with BMIs <23 kg/m
2
. A 
British study reported that obese individuals with 
insufficient vitamin D had a 32-times higher risk for 
insulin resistance compared to those who are non-
obese. To clarify this link a study reported that VD 
improves both β-cell function and the insulin sensitivity 
of target cells (liver, skeletal muscle, and adipose 
tissue) and protects β-cells from harmful immune 
attacks [41]. 
In our study a correlation is seen between 
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vitamin D serum level and cognitive functions (short-
term memory and attention scores) .This can be 
explained that vitamin D is important for fat 
metabolism, glucose metabolism and cognitive 
functions, which is translated as low vitamin D leads 
to obesity, insulin resistance and cognitive functions 
impairment. Previous studies reported an association 
between obesity and insulin resistance [38, 42]. The 
relation between insulin resistance and cognitive 
decline, especially memory impairment was 
mentioned in some studies [17]. Worldwide, 
approximately 347 million people are affected by 
diabetes, mainly type 2 diabetes. Recent 
epidemiological studies suggest that diabetic patients 
are at increased risk of dementia [18, 37]. The 
question whether the observed associations between 
these three ageing-related diseases are the result of 
shared risk factors or specific biological mechanisms, 
however, remains to be solved. Vitamin D deficiency 
is one of the postulated links. Vitamin D administration 
could be a multi-target stabilizing treatment for 
cognitive impairment and dementia. 
Lastly, our study showed that VD levels 
correlates negatively with parathyroid hormone (PTH) 
levels which is logical and has been previously 
reported. A study reported that serum VD and PTH 
levels correlate inversely. The VD levels at which PTH 
is maximally suppressed and below which PTH begins 
to rise (inflection point) has been used to define 
optimum VD levels. In overweight and obese children, 
the PTH axis is activated at much lower VD levels 
than in normal weight children. Increased PTH 
promotes calcium influx into adipocytes, where 
intracellular calcium enhances lipogenesis PTH 
excess may also promote weight gain. Therefore, the 
association between V D and obesity could change 
depending on serum PTH [43, 44]. 
In conclusion, our study shows VD deficiency 
among the obese females accompanied by cognitive 
impairment. After 2 months of balanced low caloric 
diet, VD levels increased, accompanied with improved 
cognitive functions and insulin resistance. We believe 
that low serum VD is a modifiable risk factor for 
obesity, insulin resistance and cognitive impairment in 
middle age Egyptian females. 
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